| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants (NCT05278663) | Eisai Co., Ltd. | 2022-04-14 |
| Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus (NCT05379725) | University of Florida | 2022-03-22 |
| Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) (NCT05203419) | Novartis Pharmaceuticals | 2022-03-15 |
| Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322) (NCT05193591) | University Hospital, Grenoble | 2022-03-11 |
| Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE (NCT06015230) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2022-03-08 |
| Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy (NCT05607368) | Nanfang Hospital, Southern Medical University | 2022-01-01 |
| SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS) (NCT05141201) | AstraZeneca | 2021-12-21 |
| Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus (NCT05261529) | Universidad de Granada | 2021-11-03 |
| Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients . (NCT05326841) | Dr Cipto Mangunkusumo General Hospital | 2021-10-03 |
| Belimumab In Early Systemic Lupus Erythematosus (NCT04956484) | Peking Union Medical College Hospital | 2021-09-01 |
| Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial (NCT04776161) | Brigham and Women's Hospital | 2021-08-02 |
| A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus (NCT04961567) | Biogen | 2021-07-16 |
| Study of VIB7734 for the Treatment of Moderate to Severely Active SLE (NCT04925934) | Amgen | 2021-05-28 |
| A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus (NCT04895241) | Biogen | 2021-05-25 |
| Trial of Belimumab in Early Lupus (NCT03543839) | Northwell Health | 2020-09-15 |
| A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus (NCT04060888) | Janssen Research & Development, LLC | 2020-07-14 |
| Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals (NCT04449653) | Progentec Diagnostics, Inc. | 2020-04-28 |
| A Pilot Study to Explore the Role of Gut Flora in Lupus (NCT04213690) | ProgenaBiome | 2020-03-02 |
| Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients (NCT04032496) | University of Toronto | 2020-01-01 |
| Effect of Insoles in Patients With Systemic Lupus Erythematosus (NCT04098055) | University of Seville | 2019-11-02 |
| A Study of LY3361237 in Participants With Systemic Lupus Erythematosus (NCT03933943) | Eli Lilly and Company | 2019-05-21 |
| Internet-Based Pain Coping Skills Training for Patients With Lupus (NCT03933839) | University of North Carolina, Chapel Hill | 2019-05-20 |
| Lupus Intervention for Fatigue Trial (NCT02653287) | Northwestern University | 2019-05-01 |
| Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus (NCT03896373) | University Hospital, Tours | 2019-04-17 |
| Mesenchymal Stromal Cells (MSC´s) in Renal Lupus (NCT03917797) | Universidad de los Andes, Chile | 2019-04-02 |
| BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) (NCT03771885) | Boehringer Ingelheim | 2019-03-16 |
| Synergetic B-cell Immunomodulation in SLE - 2nd Study. (NCT03747159) | Leiden University Medical Center | 2018-10-01 |
| Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus (NCT03527472) | Vanderbilt University Medical Center | 2018-08-23 |
| Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus (NCT03312335) | Onur Boyman, MD | 2018-08-08 |
| Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques (NCT03687138) | Natalia A. Rivera García | 2018-06-15 |
| Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus (NCT03746197) | National Jewish Health | 2018-06-06 |
| Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone (NCT03187743) | Assistance Publique - Hôpitaux de Paris | 2018-04-17 |
| A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus (NCT03517722) | Janssen Research & Development, LLC | 2018-04-16 |
| Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD) (NCT03504540) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-04-05 |
| Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus (NCT03427151) | ImmuPharma | 2018-02-27 |
| An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus (NCT03407482) | Genentech, Inc. | 2018-01-09 |
| Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain (NCT02822989) | Northwell Health | 2017-11-01 |
| A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE (NCT03098823) | Ampel BioSolutions, LLC | 2017-09-12 |
| A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus (NCT03161483) | Celgene | 2017-08-31 |
| Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus (NCT03142711) | Lupus Research Alliance | 2017-08-21 |
| Acupressure for Fatigue in Systemic Lupus Erythematosus (NCT03200548) | Suzanna Zick | 2017-08-14 |
| Improving the Assessment of SLE Disease Activity (NCT03144063) | University Health Network, Toronto | 2017-07-11 |
| Pilot Study to Investigate Contemplative Intervention in Lupus Patients (NCT03103243) | University of Virginia | 2017-04-27 |
| Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization (NCT03142412) | DxTerity Diagnostics | 2017-04-17 |
| Women Empowered to Live With Lupus Study (NCT02988661) | Emory University | 2017-01-19 |
| Acthar Gel for Active Systemic Lupus Erythematosus (SLE) (NCT02953821) | Mallinckrodt | 2016-12-16 |
| Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud (NCT03027674) | Pontificia Universidad Catolica de Chile | 2016-08-01 |
| Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) (NCT02732470) | University Hospital, Limoges | 2016-04-25 |
| TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment (NCT02711813) | Theramab LLC | 2016-03-01 |
| The Role of Lipids in Immune Cell Function in SLE Patients (NCT04361734) | University College, London | 2016-02-15 |
| A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus (NCT02349061) | Janssen Research & Development, LLC | 2015-10-15 |
| Effect of Green Tea on Treatment of Lupus (NCT02875691) | Ahvaz Jundishapur University of Medical Sciences | 2015-09-01 |
| Autologous Polyclonal Tregs for Lupus (NCT02428309) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-08-27 |
| A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus (NCT02437890) | Ablynx, a Sanofi company | 2015-07-01 |
| A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus (NCT02504645) | ImmuPharma | 2015-03-01 |
| Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) (NCT02070978) | EMD Serono | 2014-07-29 |
| A Complex Contraception Registry (NCT02219269) | University of California, San Diego | 2014-06-01 |
| Systemic Lupus Erythematous and Heart Conduction Disorders (NCT02162992) | Germans Trias i Pujol Hospital | 2014-04-01 |
| Synergetic B-cell Immodulation in SLE (NCT02284984) | Leiden University Medical Center | 2014-03-01 |
| Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus (NCT01972568) | EMD Serono | 2013-12-01 |
| Employment and Arthritis: Making it Work (NCT01852851) | University of British Columbia | 2013-06-01 |
| A Non-drug Study Profiling Cutaneous Lupus (NCT01923415) | Janssen Research & Development, LLC | 2013-04-01 |
| An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults (NCT01753193) | MedImmune LLC | 2013-03-28 |
| Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus (NCT01764594) | UCB Pharma | 2013-01-01 |
| Anti-ficolin-2 Autoantibodies in Lupus Nephritis (NCT03063281) | University Hospital, Grenoble | 2012-11-01 |
| Comparative Autoantibody and Immunologic Cell Marker Study (NCT02422875) | Emory University | 2012-08-01 |
| Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions (NCT01597050) | Rigel Pharmaceuticals | 2012-08-01 |
| Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients (NCT04266860) | Qure Healthcare, LLC | 2012-03-01 |
| Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis (NCT01582880) | Joseph B. Ciolino, MD | 2012-03-01 |
| Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus (NCT01405196) | Pfizer | 2011-12-01 |
| Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus (NCT01471301) | Federal University of São Paulo | 2011-06-01 |
| GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases (NCT01257802) | Joseph Mccune | 2011-05-01 |
| Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification (NCT02799173) | Centre Hospitalier Universitaire, Amiens | 2011-04-15 |
| Evaluation of the Influence of Food Regimen on Oshadi D Absorption (NCT01327352) | Oshadi Drug Administration | 2011-04-01 |
| A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus (NCT01127321) | MedImmune LLC | 2010-05-01 |
| Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment (NCT01060410) | Sun Yat-sen University | 2010-05-01 |
| Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) (NCT01093911) | UCB Pharma | 2010-03-01 |
| Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE (NCT01702038) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus (NCT00714116) | Pfizer | 2009-03-01 |
| Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis (NCT00774852) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus (NCT00657189) | MedImmune LLC | 2008-07-01 |
| Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) (NCT00624338) | EMD Serono | 2008-01-01 |
| A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus (NCT01702740) | Centocor Research & Development, Inc. | 2007-03-01 |
| European Society of Cutaneous Lupus Erythematosus (EUSCLE) (NCT00420121) | European Society of Cutaneous Lupus Erythematosus e.V. | 2007-01-01 |
| Phase Ib Study of SC Milatuzumab in SLE (NCT01845740) | Gilead Sciences | 2007-01-01 |
| Sirolimus for Autoimmune Disease of Blood Cells (NCT00392951) | Children's Hospital of Philadelphia | 2006-12-01 |
| TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) (NCT00368264) | Medical University of Vienna | 2006-09-01 |
| A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus (NCT00381810) | Genentech, Inc. | 2006-06-22 |
| A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus (NCT00137969) | Genentech, Inc. | 2005-05-10 |
| Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) (NCT00113971) | UCB Pharma | 2005-04-01 |
| Study of LJP 394 in Lupus Patients With History of Renal Disease (NCT00089804) | La Jolla Pharmaceutical Company | 2004-10-01 |
| Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) (NCT00094380) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus (NCT00325741) | Stanford University | 2004-06-01 |
| Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus (NCT00076752) | National Cancer Institute (NCI) | 2004-01-30 |
| Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis (NCT00125307) | Chinese University of Hong Kong | 2004-01-01 |
| Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) (NCT00071487) | Human Genome Sciences Inc. | 2003-10-01 |
| Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) (NCT00065806) | Laura Schanberg | 2003-09-01 |
| Physical Therapy for Systemic Lupus Erythematosus (SLE) (NCT00152555) | University of Chicago | 2003-03-01 |
| Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome (NCT00025818) | Allergan | 2001-05-01 |
| Anti-CD20 in Systemic Lupus Erythematosus (NCT00036491) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-01 |